{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:21:50Z","timestamp":1773872510330,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ogc.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,6,2]],"date-time":"2013-06-02T04:31:27Z","timestamp":1370147487000},"page":"359-376","source":"Crossref","is-referenced-by-count":28,"title":["Vulvar and Vaginal HPV Disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Erin L.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen K.","family":"Stockdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2013.03.003_bib1","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis","volume":"151","author":"Myers","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.ogc.2013.03.003_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2013.03.003_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/524875","article-title":"Risk of female human papillomavirus acquision associated with first male sex partner","volume":"197","author":"Winer","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2013.03.003_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications of clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.ogc.2013.03.003_bib5","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1172\/JCI57149","article-title":"The known unknowns of HPV natural history","volume":"121","author":"Gravitt","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ogc.2013.03.003_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase iii trials of a quadrivalent vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2013.03.003_bib7","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomized controlled trial","volume":"340","author":"FutureI\/II Study Group","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ogc.2013.03.003_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"issue":"Suppl 3","key":"10.1016\/j.ogc.2013.03.003_bib9","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Burden and management of noncancerous HPV related-conditions; HPV 6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ogc.2013.03.003_bib10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/514964","article-title":"External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts","volume":"27","author":"Beutner","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2013.03.003_bib11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"Cervical Cytology Screening. ACOG Practice Bulletin No 131","volume":"120","author":"American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib12","doi-asserted-by":"crossref","first-page":"500.e1","DOI":"10.1016\/j.ajog.2008.03.064","article-title":"The economic burden of noncervical human papillomavirus disease in the United States","volume":"198","author":"Hu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2013.03.003_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/GRF.0b013e31818092a3","article-title":"New approaches to external genital warts and vulvar intraepithelial neoplasia","volume":"51","author":"Kennedy","year":"2008","journal-title":"Clin Obstet Gynecol"},{"issue":"RR-12","key":"10.1016\/j.ogc.2013.03.003_bib14","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 2","key":"10.1016\/j.ogc.2013.03.003_bib15","first-page":"S10","article-title":"External genital warts: diagnosis, treatment and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2013.03.003_bib16","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1086\/514722","article-title":"Genital warts and their treatment","volume":"28","author":"Beutner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2013.03.003_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2005.02.012","article-title":"Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients","volume":"97","author":"van Seters","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2013.03.003_bib18","first-page":"741","article-title":"Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma","volume":"84","author":"Jones","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2013.03.003_bib19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.AOG.0000187301.76283.7f","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"106","author":"Jones","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.ogc.2013.03.003_bib21","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1089\/jwh.2009.1570","article-title":"Update of HPV-associated female genital cancers in the United States, 1999-2004","volume":"18","author":"Watson","year":"2009","journal-title":"J\u00a0Womens Health"},{"issue":"4","key":"10.1016\/j.ogc.2013.03.003_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0b013e31819bd6e0","article-title":"Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors","volume":"113","author":"Smith","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib23","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/AOG.0b013e31823b17c2","article-title":"Management of vulvar intraepithelial neoplasia. Committee Opinion No 509","volume":"118","author":"American College of Obstetricians and Gynecologists","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2013.03.003_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ygyno.2007.06.003","article-title":"Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double-blinded study","volume":"107","author":"Mathiesen","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"14","key":"10.1016\/j.ogc.2013.03.003_bib25","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa072685","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod","volume":"358","author":"van Seters","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2013.03.003_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ygyno.2010.12.340","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial","volume":"121","author":"Terlou","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2013.03.003_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2005.08.012","article-title":"Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomy","volume":"100","author":"Hillemanns","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ogc.2013.03.003_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/01.AOG.0000258783.49564.5c","article-title":"Surgical treatments for vulvar and vaginal dysplasia: a randomized controlled trial","volume":"109","author":"von Gruenigen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib29","series-title":"SGO clinical practice guidelines: management of gynecologic cancers","author":"Society of Gynecologic Oncologists Medical Practice and Ethics Committee","year":"1996"},{"key":"10.1016\/j.ogc.2013.03.003_bib30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0029-7844(98)00350-0","article-title":"Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence","volume":"92","author":"Modesitt","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2013.03.003_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00016349209007969","article-title":"Sexual function and somatopsychic reactions after local excision of vulvar intra-epithelial neoplasia","volume":"71","author":"Thueson","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.ogc.2013.03.003_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/LGT.0b013e3182410544","article-title":"Vulvar intraepithelial neoplasia: evaluation of treatment modalities","volume":"16","author":"Riberio","year":"2012","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.ogc.2013.03.003_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2012.07.118","article-title":"Vulvar intraepithelial neoplasia (VIN 2\/3): comparing clinical outcomes and evaluating risk factors for recurrence","volume":"127","author":"Wallbillich","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2013.03.003_bib34","first-page":"295","article-title":"Vulvar intraepithlial neoplasia and vulvar cancer","volume":"23","author":"Edwards","year":"1996","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"9574","key":"10.1016\/j.ogc.2013.03.003_bib35","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2013.03.003_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0002-9378(97)80018-X","article-title":"Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence and invasion and its management","volume":"176","author":"Sillman","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00003081-198106000-00011","article-title":"Carcinoma in situ of the vagina","volume":"24","author":"Woodruff","year":"1981","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib38","first-page":"75","article-title":"Human papillomavirus associated with vaginal intraepithelial neoplasia in women exposed to diethylstilbesterol in utero","volume":"70","author":"Bornstein","year":"1987","journal-title":"Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.ogc.2013.03.003_bib39","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1001\/jama.1984.03350210027024","article-title":"Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women","volume":"252","author":"Robboy","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2013.03.003_bib40","first-page":"639","article-title":"Primary invasive carcinoma of the vagina","volume":"76","author":"Manetta","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1471-0528.1990.tb01717.x","article-title":"How frequently need vaginal smears be taken after hysterectomy for cervical intraepithelial neoplasia?","volume":"97","author":"Gemmell","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib42","doi-asserted-by":"crossref","first-page":"113.e1","DOI":"10.1016\/j.ajog.2008.02.026","article-title":"Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study","volume":"199","author":"Schockeart","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ogc.2008.10.002","article-title":"Colposcopy of the vagina and vulva","volume":"35","author":"Gagne","year":"2008","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ogc.2013.03.003_bib44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/gyno.2001.6401","article-title":"Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia","volume":"83","author":"Dodge","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2013.03.003_bib45","first-page":"580","article-title":"Topical 5-fluorouracil treatment of vaginal intraepithelial neoplasia","volume":"58","author":"Caglar","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-0528.1985.tb01096.x","article-title":"Topical 5-fluorouracil in the treatment of vaginal intraepithelial neoplasia","volume":"92","author":"Kirwan","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ogc.2013.03.003_bib47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0090-8258(90)90180-S","article-title":"Vaginal intraepithelial neoplasia","volume":"36","author":"Audet-LaPoint","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2013.03.003_bib48","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1525-1438.2005.00152.x","article-title":"Can local application of imiquimod cream be an alternative mode of therapy for patients with high-grade intraepithelial lesions of the vagina?","volume":"15","author":"Haidopoulos","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ogc.2013.03.003_bib49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200208013470521","article-title":"Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream","volume":"347","author":"Diakomanolis","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ogc.2013.03.003_bib50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jjco\/hyi176","article-title":"Therapeutic effect of topical applications of tricholoracetic acid for vaginal intraepithelial neoplasia after hysterectomy","volume":"35","author":"Lin","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ogc.2013.03.003_bib51","series-title":"The principles and practice of gynecologic oncology","first-page":"820","article-title":"Treatment of VaIN","author":"Hoskins","year":"2000"},{"key":"10.1016\/j.ogc.2013.03.003_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2007.03.005","article-title":"20-year retrospective review of medium dose rate intracavitary brachytherapy in VAIN3","volume":"106","author":"Graham","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2013.03.003_bib53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1634\/theoncologist.2010-0326","article-title":"Low dose rate definitive brachytherapy for high-grade vaginal intraepithelial neoplasia","volume":"16","author":"Blanchard","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ogc.2013.03.003_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijgo.2008.11.040","article-title":"Ultrasonic surgical aspiration for vaginal intraepithelial neoplasia","volume":"105","author":"Matsuo","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2013.03.003_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/gyno.2000.5881","article-title":"Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia","volume":"78","author":"Robinson","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2013.03.003_bib56","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/LGT.0b013e31823da7fb","article-title":"Management of vaginal intraepithelial neoplasia","volume":"16","author":"Gurumurthy","year":"2012","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ogc.2013.03.003_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/IJWH.S4517","article-title":"Prevention of cervical, vaginal and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine","volume":"1","author":"Diaz","year":"2009","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.1016\/j.ogc.2013.03.003_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV 16\/18 ASO4-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia; 4-year end-of-study analysis of the randomised double-blind PATRICIA trial","volume":"13","author":"HPV PATRICIA Study Group","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ogc.2013.03.003_bib59","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"DeVuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2013.03.003_bib60","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: burden of other HPV-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J\u00a0Adolesc Health"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854513000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854513000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T14:34:50Z","timestamp":1595860490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854513000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0889854513000284"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2013.03.003","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}